27 Jun, EOD - Indian

Nifty 50 25637.8 (0.35)

Nifty Pharma 21928.6 (0.55)

Nifty IT 38822.95 (-0.44)

Nifty Next 50 68712.4 (0.61)

SENSEX 84058.9 (0.36)

Nifty Midcap 100 59385.15 (0.27)

Nifty Bank 57443.9 (0.41)

Nifty Smallcap 100 18976.8 (0.91)

27 Jun, EOD - Global

NIKKEI 225 40150.79 (1.43)

HANG SENG 24284.15 (-0.17)

S&P 6232.75 (0.41)

LOGIN HERE

companylogoAmbar Protein Industries Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 519471 | NSE Symbol : | ISIN : INE072V01017 | Industry : Solvent Extraction |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
23-May-2025 30-May-2025 Accounts Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the audited Standalone Financial Results of the Company for the Quarter and Year ended March 31 2025. Outcome of Board Meeting (As per BSE Announcement Dated on 30/05/2025)
04-Feb-2025 08-Feb-2025 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve 1. The UnAudited Financial Results of the Company for the Quarter and Nine month ended on 31st December 2024. 2. Review Installation of New Machinery. 3. Any other business with permission of the Chairperson. Un Audited Quaterly Financial Report for Quater December 2024 Outcome of Board Meeting (As Per BSE Announcement Dated on 08/02/2025)
21-Oct-2024 26-Oct-2024 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2024 inter alia to consider and approve The UnAudited Financial Results of the Company for the Quarter and Half Year ended on 30th September 2024. OUTCOME- FINANCIAL RESULT AS ON 30TH SEPTEMBER 2024 OUTCOME (As Per BSE Announcement Dated on 26.10.2024)
07-Sep-2024 11-Sep-2024 Others Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/09/2024 inter alia to consider and approve 1. To Repay Secure Loan except working capital loans to make Company debt free. 2. To Launch New Products namely: a. Cold Pressed Groundnut Oil b. Cold Pressed Extra Vergin Coconut Oil c. Cold Pressed Sesame oil d. Cold Pressed Mustard Oil The Board of Directors of the Company as its meeting held on 11th September 2024, and the same meeting commenced at 12.30 p.m and concluded at 12:45 p.m. In that meeting the Board has decided following matters: 1. Considered and approved to Repay Secure Loan except working capital loans to make Company debt free. 2. Considered and approved to setup new Machineries for Launch New Products namely: a. Cold Pressed Groundnut Oil, b. Cold Pressed Extra Vergin Coconut Oil, c. Cold Pressed Sesame oil, d. Cold Pressed Mustard Oil 3. Noted Fine as per SEBI circular no. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 (Chapter VII(A)-Penal Action for Non-Compliance) of Rs. 21240/- imposed by BSE for late compliance under Regulation 27(2)-Non-submission of the corporate governance compliance report within the period provided under this regulation. (As Per BSE Announcement dated on 11.09.2024)
09-Aug-2024 14-Aug-2024 AGM Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the Meeting of Board of Directors of the Company will be held on 14th August 2024 at 12:30 Pm at the Register Office of the Company situated at Sarkhej - Bavla Highway Opp Bhagyoday Hotel Ahmedabad to consider and approve: 1. The UnAudited Financial Results of the Company for the Quarter ended on 30th June 2024. 2. Board Report for year ended 31.03.2024. 3. The notice and date of 30th Annual General Meeting of the Members of the Company. 4. To transact various other businesses as per the agenda. OUTCOME OF MEETING: FINANCIAL RESULT AS ON 30TH JUNE, 2024 (As Per BSE Announcement dated on 14.08.2024)
23-May-2024 30-May-2024 Accounts Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve 1. The Audited Financial Results of the Company for the Quarter and Year ended on 31st March 2024. 2. Re-Appointment of Shri Pradeep khetani as Managing Director of the Company. 3. Re-Appointment of Shri Jayprakash vachhani as Whole-Time director of the Company. 4. Related Party Transections with Ankur Oil Industries. 5. To transact various other businesses as per the Agenda. OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 30.05.2024)
06-Feb-2024 14-Feb-2024 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. The UnAudited Financial Results of the Company for the Quarter and Nine month ended on 31st December 2023. 2. The Extra ordinary General Meeting date. OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 14.02.2024)
30-Jan-2024 06-Feb-2024 Change in Auditors Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve To fill casual vacancy caused due to Resignation of Existing Auditor We wish to inform you that at its meeting held on today 06th February 2024 at 3:00 PM and concluded at 5:50 PM the Board of Directors of the Company approved: 1. The appointment of M/s Fenil P Shah & Associates., Chartered Accountants, (FRN: 143571W) as Statutory Auditors of the Company, subject to the approval of shareholders of the company at their ensuing General Meeting. 2. Next Board Meeting to be held on Wednesday 14th, February 2024 APPOINTMENT OF STATUTORY AUDITOR (As per BSE Announcement Dated on 06/02/2024)
31-Oct-2023 07-Nov-2023 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve UnAudited Financial Results of the Company for the Quarter and Half Year ended on 30th September 2023 Statement of Un-Audited Financial Result for quarter/half year ended on 30th september, 2023 outcome of board meeting held on 07.11.2023 (As Per BSE Announcement Dated on 07.11.2023)
03-Aug-2023 12-Aug-2023 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve 1. The UnAudited Financial Results of the Company for the Quarter ended on 30th June 2023. 2. Board Report for year ended 31.03.2023. 3. The purchase of New Sunflower Refinery capacity upto 200 TPD. 4. The notice and date of 30th Annual General Meeting of the Members of the Company. 5. To transact various other businesses as per the agenda. OUTCOME OF BOARD MEETING DATED 12.08.2023 (As per BSE Announcement Dated on 12/08/2023)
24-May-2023 30-May-2023 Accounts Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31 2023 We wish to inform you that at its meeting held on today 30th May, 2023 at 3:30 PM and concluded at 4:15 PM the Board of Directors of the Company has considered and approved: 1. The Audited Financial Result for the Quarter and Year ended on 31st March 2023. 2. Appointed Ms. Saloni Shah, Practicing Company Secretary as Secretarial Auditor of the Company for Secretarial Audit of the company for FY 2023-24. 3. Appointed Rajendra Natverlal Shah & Co. FRN No. 0130209W as an internal Auditor of the Company for FY 2023-24. (As Per BSE Announcement Dated on 30.05.2023)
24-Jan-2023 31-Jan-2023 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve and take on record the unaudited financial results of the Company for the quarter and nine months ended December 31 2022 Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we wish to inform you that the Board of Directors at its meeting held today, have considered and approved the Un-audited financial results as per Indian Accounting Standards (Ind-AS) for the quarter and nine months ended December 31, 2022. A copy of the un-audited financial results along with the Limited Review Reports is enclosed herewith Intimation regarting NEW PRODUCT LAUNCH (As Per BSE Announcement Dated on 31.01.2023)
05-Nov-2022 14-Nov-2022 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30 2022. Unaudited Financial Results For The Quarter Ended September 30, 2022 (As Per BSE Announcement Dated on 14.11.2022)
05-Aug-2022 13-Aug-2022 Quarterly Results Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve the Unaudited financial results of the Company for the quarter ended 30th June 2022 Pursuant to regulation 30 & 33 of the SEBI (LODR) Regulations, 2015, submission of Financial Results for June 30, 2022 OUTCOME OF BOARD MEETING DATED 13.08.2022- AGM ON 30.09.2022 The Register of Member and Share Transfer Register of the Company will remain closed from Thursday 22/09/2022 to Friday 30/09/2022 (Both days inclusive). (As Per BSE Announcement Dated on 13/08/2022)
23-May-2022 30-May-2022 Accounts Ambar Protein Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve and take on record the Audited Financial Results of the Company for the fourth quarter and year ended 31st March 2022. This is for your information and record. Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, We enclosed the following: 1. Statement of Audited Financial Result along with Statement of Assets and Liabilities for the Quarter and year ended on 31st March 2022. 2. Auditors Report on Audited Financial Result. 3. Declaration w.r.t Audited Report with unmodified opinion on Audited Financial Result for the quarter and year ended on 31st March 2022. (As Per BSE Announcement Dated on 30/05/2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +